Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling J EXP MED
The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78 Blood
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project Blood
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia CANCER CELL
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas Nat Med
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models P NATL ACAD SCI USA
Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines Cancer Res